Proposed Data Collection Submitted for Public Comment and Recommendations, 80105-80106 [2020-27325]
Download as PDF
<![CDATA[
80105
Federal Register / Vol. 85, No. 239 / Friday, December 11, 2020 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents
Agency Stakeholders ......................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–27322 Filed 12–10–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-21–21BL; Docket No. CDC–2020–
0120]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled, ‘‘Evaluation of the Overdose Data
to Action Technical Assistance Hub’’.
This proposed collection will be used to
monitor and evaluate the effectiveness
and impact of technical assistance (TA)
provided to Overdose Data to Action
(OD2A) program recipients funded to
implement opioid surveillance and
prevention efforts in their jurisdictions.
DATES: CDC must receive written
comments on or before February 9,
2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0120 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
23:25 Dec 10, 2020
Jkt 253001
Number of
respondents
Form name
SMS Text Survey ...........................................
ACAS Sign In Sheet ......................................
Hardcopy ACAS .............................................
Online ACAS ..................................................
SMS Text Survey ...........................................
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
PO 00000
Frm 00116
Fmt 4703
Sfmt 4703
150
42
26
16
50
Number of responses per
respondent
1
1
1
1
1
Avg. burden
per response
(in hrs.)
3/60
2/60
15/60
15/60
3/60
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Evaluation of the Overdose Data to
Action Technical Assistance Hub—
New—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Division of Overdose Prevention
(DOP), at Centers for Disease Control
and Prevention (CDC) requests a threeyear OMB approval to support the
evaluation of technical assistance (TA)
provided for the Overdose Data to
Action (OD2A) program. OD2A is a
cooperative agreement (CDC–RFA–
CE19–1904) funded in 2019 to focus on
comprehensive and interdisciplinary
opioid overdose prevention efforts in 47
state health departments, 16 localities,
Puerto Rico, Washington DC, and the
North Mariana Islands. This program
consists of two required components– a
surveillance component and a
prevention component. OD2A recipients
implement a combination of activities
across ten strategies within these
components in order to gain access to
high quality, complete, and timelier
data on opioid prescribing and
overdoses and to use those data to
inform prevention and response efforts
in their jurisdictions.
Training and technical assistance
(TA) is essential to building knowledge
and strengthening the capacity of
recipients to implement and evaluate
OD2A program strategies. CDC will
develop and deploy a TA hub (hereafter
referred to as the OD2A TA Center) to
deliver comprehensive technical
assistance and training to support the
E:\FR\FM\11DEN1.SGM
11DEN1
80106
Federal Register / Vol. 85, No. 239 / Friday, December 11, 2020 / Notices
successful implementation and
evaluation of surveillance and
prevention activities. The OD2A TA
Center is designed to enhance the
efficiency, coordination, and
effectiveness of TA efforts by
streamlining and centralizing the
provision of overdose surveillance and
prevention TA. TA to OD2A recipients
is divided into four different levels with
multiple modes of TA delivery and
involves a wide range of TA providers
including CDC staff, internal and
external subject matter experts (SMEs)
and program partners as well as ICF
staff.
obtained through this evaluation will
allow TA providers to assess OD2A
recipients’ experience and utility of
knowledge and resources gained
through individual TA support, peer-topeer sessions, and other group trainings.
Ultimately, the evaluation data will
inform subsequent rounds of TA and
allow TA providers to make necessary
adjustments to the overall TA strategy
for continuous quality improvement.
This will ensure recipients have the
support necessary to implement
strategies that will improve opioid
surveillance and prevention policies
and practices within their communities.
The evaluation consists of two webbased surveys designed to collect
process and outcome measures about
TA access, utilization, and outcomes
across all 66 OD2A recipient programs.
The Technical Assistance Feedback
Form will be administered to collect
immediate feedback following
individual TA encounters and group
events such as webinars and in-person
trainings. The Annual OD2A TA Survey
will be distributed twice (mid-point and
final) to assess satisfaction with overall
TA provided and the extent to which
TA supports informed implementation
of OD2A strategies. The information
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
OD2A Recipients ..............................
Annual OD2A TA Survey ..................
TA Feedback Form ..........................
...........................................................
671
440
2
1
5/60
15/60
112
110
Total ...........................................
...........................................................
........................
........................
........................
222
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–27325 Filed 12–10–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–20OT]
Agency Forms Undergoing Paperwork
Reduction Act Review
jbell on DSKJLSW7X2PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Mycoplasma
genitalium Treatment Failure Registry’’
to the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on June 5, 2020 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
VerDate Sep<11>2014
00:32 Dec 11, 2020
Jkt 253001
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
PO 00000
Frm 00117
Fmt 4703
Sfmt 4703
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Mycoplasma genitalium Treatment
Failure Registry—New—National Center
for HIV/AIDS, Viral Hepatitis, STD, and
TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC), Division of STD
Prevention requests a three-year
approval of an information collection
request for the Mycoplasma genitalium
Treatment Failure Registry, which will
entail use of a standardized Case Report
Form.
The primary goal of this activity is to
establish a registry to monitor cases of
Mycoplasma genitalium (M. genitalium)
treatment failure in the United States.
The project objectives are as follows: (1)
Using existing clinical data, describe
demographic and behavioral factors
among patients with documented
Mycoplasma genitalium who fail
current CDC-recommended treatment,
(2) Using existing clinical data, describe
antibiotic regimens utilized among
patients with Mycoplasma genitalium
treatment failure, including
documentation of clinical and
E:\FR\FM\11DEN1.SGM
11DEN1
]]>Agencies
[Federal Register Volume 85, Number 239 (Friday, December 11, 2020)]
[Notices]
[Pages 80105-80106]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-27325]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-21BL; Docket No. CDC-2020-0120]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled, ``Evaluation of the Overdose
Data to Action Technical Assistance Hub''. This proposed collection
will be used to monitor and evaluate the effectiveness and impact of
technical assistance (TA) provided to Overdose Data to Action (OD2A)
program recipients funded to implement opioid surveillance and
prevention efforts in their jurisdictions.
DATES: CDC must receive written comments on or before February 9, 2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0120 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Evaluation of the Overdose Data to Action Technical Assistance
Hub--New--National Center for Injury Prevention and Control (NCIPC),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Division of Overdose Prevention (DOP), at Centers for Disease
Control and Prevention (CDC) requests a three-year OMB approval to
support the evaluation of technical assistance (TA) provided for the
Overdose Data to Action (OD2A) program. OD2A is a cooperative agreement
(CDC-RFA-CE19-1904) funded in 2019 to focus on comprehensive and
interdisciplinary opioid overdose prevention efforts in 47 state health
departments, 16 localities, Puerto Rico, Washington DC, and the North
Mariana Islands. This program consists of two required components- a
surveillance component and a prevention component. OD2A recipients
implement a combination of activities across ten strategies within
these components in order to gain access to high quality, complete, and
timelier data on opioid prescribing and overdoses and to use those data
to inform prevention and response efforts in their jurisdictions.
Training and technical assistance (TA) is essential to building
knowledge and strengthening the capacity of recipients to implement and
evaluate OD2A program strategies. CDC will develop and deploy a TA hub
(hereafter referred to as the OD2A TA Center) to deliver comprehensive
technical assistance and training to support the
[[Page 80106]]
successful implementation and evaluation of surveillance and prevention
activities. The OD2A TA Center is designed to enhance the efficiency,
coordination, and effectiveness of TA efforts by streamlining and
centralizing the provision of overdose surveillance and prevention TA.
TA to OD2A recipients is divided into four different levels with
multiple modes of TA delivery and involves a wide range of TA providers
including CDC staff, internal and external subject matter experts
(SMEs) and program partners as well as ICF staff.
The evaluation consists of two web-based surveys designed to
collect process and outcome measures about TA access, utilization, and
outcomes across all 66 OD2A recipient programs. The Technical
Assistance Feedback Form will be administered to collect immediate
feedback following individual TA encounters and group events such as
webinars and in-person trainings. The Annual OD2A TA Survey will be
distributed twice (mid-point and final) to assess satisfaction with
overall TA provided and the extent to which TA supports informed
implementation of OD2A strategies. The information obtained through
this evaluation will allow TA providers to assess OD2A recipients'
experience and utility of knowledge and resources gained through
individual TA support, peer-to-peer sessions, and other group
trainings. Ultimately, the evaluation data will inform subsequent
rounds of TA and allow TA providers to make necessary adjustments to
the overall TA strategy for continuous quality improvement. This will
ensure recipients have the support necessary to implement strategies
that will improve opioid surveillance and prevention policies and
practices within their communities.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
OD2A Recipients............... TA Feedback Form 671 2 5/60 112
Annual OD2A TA Survey......... ................ 440 1 15/60 110
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 222
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-27325 Filed 12-10-20; 8:45 am]
BILLING CODE 4163-18-P
